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ABSTRACT
Background: As the global efforts to curb the human immuno deficiency virus (HIV) 
pandemic continues, one key intervention is the promotion of effective family planning 
options for HIV positive women in the reproductive age group.
Objectives: To evaluate the level of awareness and utilisation of contraceptives among 
HIV positive women attending anti-retroviral (ARV) clinic in Port Harcourt, South-
South Nigeria and also determine the pattern of contraceptive use before and after 
sero-conversion.
Design: Descriptive cross-sectional Hospital based study
Setting: Anti-retroviral (ARV) clinic, University of Port Harcourt Teaching Hospital, 
(UPTH), Port Harcourt, Nigeria.
Subjects: One hundred and seventy HIV positive women in the reproductive age on  
highly active anti-retroviral  therapy (HAART) 
Results: The mean age of the respondents was 34.34 ± 0.66 years with a range of 
22-55years and parity range of 0-6 with a median parity of 2. Although majority (76%) 
of respondents were aware of contraceptives, only 49 (28.82%) were using contraception 
before diagnosis of HIV infection, but the uptake increased to  almost 100% after 
knowledge of sero-conversion, with majority using male condom. Up to 55 (32.4%) 
respondents were sero-concodant with sexual partners, 46 (27.1%) sero-discodant while 
69(40.6%) were not aware of their partners sero-status.
Conclusion: There is extremely high knowledge and uptake of family planning after 
diagnosis of sero-conversion among HIV positive women attending the ARV clinic 
in Port Harcourt with the male condom as the most preferred method. This may have 
contributed to the reportedly overall slowly declining HIV prevalence. 
INTRODUCTION
As the global HIV pandemic and burden persists 
especially in developing countries, concerted efforts 
are tremendously being made to tame the spread 
including the promotion of family planning methods 
to HIV infected women in the reproductive age group. 
Despite the efforts, the World Health Orgnisation 
(WHO) estimates that well over 42 million people are 
still living with HIV or acquired immune deficiency 
syndrome (AIDS) worldwide and 50% of all adults 
with HIV are women predominantly infected through 
heterosexual transmission (1). About 14 million 
women in sub-Saharan Africa are HIV positive (2), 
and in Nigeria an estimated 2.6 million adult aged 
between 15 and 49 years are sero-positive for HIV (3).
 Majority of women at risk of HIV infection are 
in the reproductive age and this age group makes up 
85% of women living with HIV/AIDS worldwide 
(1,4), hence it has become a major challenge to design 
an effective contraceptive method to prevent HIV 
transmission and unintended pregnancies amongst 
this group (4,5).
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Interestingly, there has not been any clearly 
demonstrated decrease in fertility among HIV 
positive women. Therefore contraceptive methods 
offerred and effectively used by HIV positive women 
have become extremely important considering their 
reproductive wishes, interaction with HIV disease, 
anti-retroviral therapy and other commonly used 
medications (4,6). The contraceptive options among 
HIV infected women must take into account the risk 
of intended pregnancy, vertical transmission and 
horizontal transmission for non-infected partner. To 
achieve these goals, a combined contraceptive have 
been advocated, preferably a barrier plus another 
method (6).
 Since the introduction of highly active anti-
retroviral therapy (HAART) in 1996, there has been 
dramatic reduction in both morbidity and mortality 
among people living with HIV (7), such that many 
patients and health care providers view HIV as a 
chronic but manageable illness (8), and like other 
women of reproductive age group, many HIV 
positive women desire child bearing and parenthood 
despite having a chronic illness. They also want safe 
and effective contraception to prevent unintended 
pregnancies, sexually transmitted infections and 
prevent HIV transmission to their sexual partners 
(7).
 Contraceptive prevalence has continued to 
vary among HIV positive women and may be 
influenced by education, ethnicity, religion, socio-
economic status parity and others (5, 9). Arowojolu 
et al reported that among the youths in western 
Nigeria, though majority have adequate knowledge 
of HIV transmission and prevention, only a few are 
taking positive preventive measures (10). Anad et 
al confirmed that in Kenya and Malawi, 32% and 
20% respectively of HIV positive women who were 
sexually active were using contraceptives (11), while 
Stuart reported a contraceptive prevalence of 21% 
among partnered women living with HIV in sub-
saharan Africa (3), and in the United States only about 
50% of HIV infected and at risk youths used effective 
contraception consistently despite its availability 
(12).  Jarbas et al, working in Brazil, demonstrated 
an increased knowledge and use of contraceptive 
methods after diagnosis of sero-conversion amongst 
women living with HIV/AIDS (13), and suggested 
that either the women who received information 
about contraceptives had never received it before 
or that the diagnosis of being HIV infected created 
stronger motivation to listen to counselling offered 
(13).
 Port Harcourt, the capital city of Rivers state, 
south-south Nigeria which has been the hub of oil and 
gas prospecting and refining activities for decades, 
plays host to several multinational companies 
and as such densely populated with people from 
diverse backgrounds. The UPTH draws its patients 
from a cross section of multi-ethnic and indigenous 
population who reside in Port Harcourt and its 
catchment states of the oil rich Niger Delta area of 
Nigeria. 
 This preliminary study was therefore done 
to evaluate the level of awareness and use of 
contraceptives among HIV positive women in the 
reproductive age group in Port Harcourt and also 
determine their contraceptive uptake pattern.
MATERIALS AND METHODS 
It was a descriptive cross sectional questionnaire 
based study of HIV positive women attending the 
Anti-retroviral (ARV) clinic of UPTH, Port Harcourt, 
South-South Nigeria. As at June 2009 when the study 
was done, about 500 HIV positive women attended 
the ARV Clinic annually at the UPTH. while the study 
subjects consisted of all the consenting 170 of these 
women who were on HAART. Those who were not 
already on HAART and who were menopausal at the 
time of the study were excluded. Inclusion criteria 
were those who were already on HAART and gave 
consent. Those who were not already on HAART, 
did not give consent, and were already menopausal 
at the time were excluded from the study. Of the 500 
women attending the ARV clinic, 170 met the inclusion 
criteria and were therefore recruited for the study.
Ethical approval was given by the Hospital Ethical 
committee: The ARV clinic was established in 
February 2002 and headed by a consultant physician, 
with supporting residents from internal medicine, 
hematology and community health departments. The 
clinic is located at the medical out patient department, 
and at its inception runs once weekly but changed to 
twice weekly in august 2006 with increasing patronage 
of almost 1000 patients annually.
 The study instrument was a structured 
interviewer administered questionnaire which 
requested information on the respondents’ socio-
demographic characteristics, contraceptive options, 
patterns and reasons and husbands’ sero-status. 
Details of the study were fully explained to the women 
before they were administered to them on each clinic 
day by trained research assistants.
 At the end of the interview, the questionnaires 
were collated and the information retrieved coded 
and entered into a personal computer using SPSS for 
windows 11.0 version. The results were presented in 
percentages, rates, means with standard deviations.
 
RESULTS
The mean age of the respondents was 34.34 ±0.66 years 
with a range of 20 - 55years, while the median parity 
was 2, with majority (54.1%) being multiparous and 
only 2 (1.2%) nulliparous.  One hundred and sixty 
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one (72.3%) of the women had at least secondary 
education, while only 9(5.9%) had no formal 
education. The socio-demographic characteristics 
are shown in Table 1.
 Although, 129(75.8%) had knowledge of 
contraception before realizing they were infected, 
only 49(38%) were practicing contraception. Of the 
32 (65.3%) using male condom before diagnosis, 
14(43.8%) changed to oral pills. The comparism 
between use of contraceptives before and after 
diagnosis is as shown in Table 2.
 However, almost all (100%) were aware of and 
used one form of contraception or the other after 
diagnosis of sero-conversion. The most common form 
of contraception was the male condom used by 119 
(70%) respondents, followed by oral pills used by 46 
(27.1%) while non accepted bilateral tubal ligation. 
Of the 119 who used the condom, majority were of 
the younger age group, 43 (36.1%) were in the age 
range of 20-29 years. The older women aged 50 years 
and above used condoms and implants inserted some 
years back. The contraceptive method used against 
the age groups is shown in Table 3.
 Almost 71.7% (122) of the women reported that 
the reason for the choice of contraceptive method 
was because it was more effective against HIV 
transmission, while 22 (12.9%) reported that it was 
more effective against pregnancy.Table 4 shows the 
reasons for choice of contraceptive used. 
 Up to 32.4% (55) of respondents were sero-
concordant with their partners, 46(27.1%) sero-
discordant while the partner’s sero-status was 
unknown in 69(40.5%) women. 
Table 1
The socio-demographic characteristics respondents
Characteristic Frequency (n) Percentage (%) of Total
           Age 
  •   20-29 61 35.9
  •   30-39 72 42.4
  •   40-49 24 14.1
  •   ≥50 13 8.6
    Marital status
  •   Married 65 38.2
  •   Single 56 32.9
  •   Divorced/Separated 13 7.6
  •   Widowed 36 21.2
  PARITY
          Nullipara 2 1
          1-2  102 60
          3-4 48 28
           ≥5 18 11
EDUCATIONAL STATUS
  •   None 9 5.3
  •   Primary 38 22.4
  •   Secondary 74 43.5
  •   Tertiary  49 28.8
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Table 2
Comparison between use of contraceptive before and after diagnosis
BEFORE DIAGNOSIS








Oral Pills  
(%)
Coil 1 (2.0) 0 (0.0) 1 (100.0) 0 (0.0) 0 (0.0)
Condoms 32 (65.3)  18 (56.3)   0 (0.0) 0 (0.0) 14 (43.8)
Injections 1 (2.0) 0 (0.0) 1 (100.0) 0 (0.0) 0 (0.0)
Oral Pills 14 (28.6) 1 (7.1)  7 (50.0) 5 (35.7) 1 (7.1)
Safe Period 1 (2.0) 0 (0.0) 1 (100.0) 0 (0.0) 0 (0.0)
Total 49 (100.0) 19 (38.8) 10 (20.4) 5 (10.2)   15 (30.6)
Table 3
Method of Contraceptive Used and Age Group
Method of Contraceptive Used Age Group
Total No 20-29 (%) 30-39 (%) 40-49 (%)    ≥50 (%)
Coil 1 (0.6) 0 (0.0) 1 (100.0) 0 (0.0) 0 (0.0)
Condoms 119 (70.0) 43 (36.1) 51 (42.9) 17 (14.3) 8 (6.7)
Implants 2 (1.2) 0 (0.0) 0 (0.0) 1 (50.0) 1 (50.0)
Injections 1 (0.6) 0 (0.0) 1 (100.0) 0 (0.0) 0 (0.0)
Oral Pills 46 (27.1) 18 (39.1) 18 (39.1) 6 (13.0) 4 (8.7)
Safe Period 1 (0.6) 0 (0.0) 1 (100.0) 0 (0.0) 0 (0.0)
Total 170(100.0) 61 (35.9) 72 (42.4) 24 (14.1) 13 (7.6)
Table 4
 Reasons for choice of contraceptive method
Reasons for contraceptive choice Number (n) % of Total
Age 1 0.6
Convenience 12 7.1
More effective against HIV transmission 122 71.7
More effective against pregnancy 22  12.9
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DISCUSSION 
There is very high knowledge and use of contraception 
after diagnosis of sero-conversion among HIV positive 
women in Port Harcourt in keeping with result of 
a Brazilian study (13). The increased knowledge 
of contraceptive method after sero-conversion 
and the increased prevalence of contraceptive use 
tend to suggest positive impact of the counseling 
done. This commendable attitude of these women 
towards contraceptive uptake may have contributed 
immensely to the reportedly declining HIV prevalence 
in Nigeria.
 However, one disturbing finding in this study 
is the fact that all the women using the condom for 
contraception prior to sero-diagnosis switched to 
other methods.They may have been disappointed 
with condom as this, in their  thinking, did not 
prevent them from acquiring the HIV. It is probable 
that they might have aquired the virus before condom 
use, were not using the condom consistently and 
effectively or may have aquired the virus from other 
routes. A more aggressive counselling in this regard 
is needed in this group of women to enable them 
prevent transmision of this virus to their partners or 
even prevent them from acquiring new strains of the 
virus. A combined contraceptive, preferably a barrier 
plus another method have earlier been advocated for 
these women (6).
 It is even more disturbing that some of them still 
do not use condom even when their partner is sero 
negative. It is possible some may not be aware of 
their partners’ sero-status or may have the erroneous 
believe that HIV does not exist. Some authors have 
also suggested that many HIV women consider 
methods to avoid pregnancy as having similar or 
more effectiveness in the transmission of the virus 
(13). This is also in keeping with the findings in this 
study where 71% of the women gave this reason for 
their choice of contraceptive as ‘more effective against 
HIV transmission’. This finding buttresses the need 
for comprehensive counselling on reproductive health 
issues, not only at the time of HIV diagnosis but also 
at every appointment at the ARV clinic. However, 
the use of behavioural methods like safe period had 
drastically reduced from these women and may not 
be unrelated to counselling received at the ARV clinic. 
It was also noted that majority of these women chose 
condom for contraception at variance with results of 
earlier study in Port Harcourt, where majority of the 
general population used injectable contraceptives 
and intra uterine contraceptive device14  Expectedly, 
non of these women opted for bilateral tubal ligation.
This reflects the prevailing contraceptive practice in 
Nigeria where tubal ligation is not a very popular 
method even among uninfected women (14), at 
variance with studies from developed countries where 
BTL is very popular contraceptive method especially 
among HIV positive women (13).
 It is reassuring to note that the younger age group 
in this study based their choice of contraceptive on 
prevention of HIV transmission and used condom 
specifically. This is quite commendable as these group 
tend be sexually more active and having protected 
intercourse will help in reducing transmission of HIV 
and other sexually aquired infections.
In conclusion, the diagnosis of HIV infection 
contributed to a greater knowledge of contraceptive 
methods and exponential improvement on its 
use. Young women within the reproductive age 
group acquiring HIV through heterosexual contact 
constitute the new wave of the HIV pandemic. They 
should therefore receive adequate contraceptive 
counseling in order to prevent HIV transmission 
to a serodiscordant partners, contracting a new 
HIV serotype and prevent unplanned pregnancy 
with consequent increased rate of mother to child 
transmittion of HIV. When these are achieved, we 
will be  further reducing the impact of HIV/AIDS 
in our society.
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